Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease.
Tong J, Li D, Meng H, Sun D, Lan X, Ni M, Ma J, Zeng F, Sun S, Fu J, Li G, Ji Q, Zhang G, Shen Q, Wang Y, Zhu J, Zhao Y, Wang X, Liu Y, Ouyang S, Sheng C, Shen F, Wang P.
Tong J, et al.
Acta Pharm Sin B. 2022 Sep;12(9):3650-3666. doi: 10.1016/j.apsb.2022.02.003. Epub 2022 Feb 12.
Acta Pharm Sin B. 2022.
PMID: 36176906
Free PMC article.